mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.088 |
0.1 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.2 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.2 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |